Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Dianthus Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
DNTH
Nasdaq
8731
https://dianthustx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Dianthus Therapeutics Inc
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- May 3rd, 2024 8:30 pm
Dianthus Therapeutics Announces Oral Presentation for DNTH103 at the 2024 American Academy of Neurology (AAN) Annual Meeting
- Apr 11th, 2024 11:30 am
Dianthus Therapeutics Insiders Added US$2.05m Of Stock To Their Holdings
- Mar 22nd, 2024 11:55 am
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial Results
- Mar 21st, 2024 8:01 pm
Dianthus Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Mar 7th, 2024 9:30 pm
Dianthus Therapeutics Announces Initiation of Phase 2 MaGic Trial of DNTH103 In Generalized Myasthenia Gravis (gMG)
- Feb 26th, 2024 12:00 pm
Institutional investors in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) have had a wonderful week after share price increased 24%
- Jan 8th, 2024 11:43 am
Here's Why We're Watching Dianthus Therapeutics' (NASDAQ:DNTH) Cash Burn Situation
- Dec 12th, 2023 10:11 am
Insider Buying: Fairmount Funds Management LLC Acquires 24,254 Shares of Dianthus Therapeutics Inc
- Sep 14th, 2023 9:04 pm
Scroll